Vasudeva Bhat
Overview
Explore the profile of Vasudeva Bhat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parsyan A, Bhat V, Athwal H, Goebel E, Allan A
Transl Oncol
. 2024 Nov;
51:102165.
PMID: 39520877
Artemis is a key nuclease involved in the non-homologous end joining repair pathway upon DNA double-stranded breaks and during V(D)J recombination. It participates in various cellular processes and cooperates with...
2.
Athwal H, Kochiyanil A, Bhat V, Allan A, Parsyan A
Front Oncol
. 2024 Apr;
14:1370565.
PMID: 38606093
Breast cancer is the most prevalent malignancy among women worldwide. Despite significant advances in treatment, it remains one of the leading causes of female mortality. The inability to effectively treat...
3.
Bhat V, Piaseczny M, Goodale D, Patel U, Sadri A, Allan A
Clin Exp Metastasis
. 2024 Apr;
41(5):717-731.
PMID: 38581619
Patients with triple-negative breast cancer (TNBC) have an increased propensity to develop lung metastasis. Our previous studies demonstrated that stem-like ALDHCD44 breast cancer cells interact with lung-derived soluble factors, resulting...
4.
Pellizzari S, Bhat V, Athwal H, Cescon D, Allan A, Parsyan A
Radiat Oncol
. 2024 Feb;
19(1):24.
PMID: 38365710
Radioresistance is one of the barriers to developing more effective therapies against the most aggressive, triple-negative, breast cancer (TNBC) subtype. In our previous studies, we showed that inhibition of Polo-like...
5.
Dhariwal N, Roy Moulik N, Bhat V, Smriti V, Kakoti S, Choudhury S, et al.
Am J Blood Res
. 2023 Nov;
13(5):162-167.
PMID: 38023415
Central nervous system (CNS) involvement in Hodgkin lymphoma (HL) is an extremely rare presentation with dismal outcomes according to reported literature. An 8-year-old girl presented to us with complaints of...
6.
Lefebvre C, Pellizzari S, Bhat V, Jurcic K, Litchfield D, Allan A
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760847
Resistance to protein tyrosine kinase inhibitors (TKIs) presents a significant challenge in therapeutic target development for cancers such as triple-negative breast cancer (TNBC), where conventional therapies are ineffective at combatting...
7.
Mande R, Roy Moulik N, Shet T, Narula G, Prasad M, Dhamne C, et al.
J Pediatr Hematol Oncol
. 2022 Feb;
44(3):e760-e764.
PMID: 35129150
Clinicopathologic profile and outcome of 15 children (15 years or above) with diffuse large B-cell lymphoma treated with MCP-842 protocol are reported. Eleven of 15 presented with advanced (stage-III/IV) disease....
8.
Breadner D, Vincent M, Correa R, Black M, Warner A, Sanatani M, et al.
Lung Cancer
. 2022 Feb;
165:145-151.
PMID: 35124411
Introduction: Blood-based liquid biopsies examining circulating tumour DNA (ctDNA) have increasing applications in non-small cell lung cancer (NSCLC). Limitations in sensitivity remain a barrier to ctDNA replacing tissue-based testing. We...
9.
Bhat V, Pellizzari S, Allan A, Wong E, Lock M, Brackstone M, et al.
Crit Rev Oncol Hematol
. 2021 Dec;
169:103566.
PMID: 34890802
Relatively poor survival outcomes are observed in advanced or metastatic breast cancer, where local control of the primary or metastatic disease may be achieved by surgical resection, local ablative and...
10.
Roy Moulik N, Bhat V, Yadav R, Narula G, Challinor J, Banavali S
Pediatr Blood Cancer
. 2021 Nov;
69(6):e29449.
PMID: 34767282
No abstract available.